Jetstream is engineered to predictably treat multiple morphologies, such as calcium, plaque or thrombus, commonly found in total occlusions. As the only atherectomy system with active aspiration, Jetstream removes debris, helping minimize the risk of distal embolization.
CLI Case Studies
CLI Case Study 1:
Complex Revascularization of Critical Limb Ischemia Patient Using Rotational Atherectomy
CLI Case Study 2:
SFA Total Occlusion in Patient with Non-Healing Ulcer
CLI Case Study 3:
Thrombotic Lesion in Popliteal Artery and Tibial Vessels
The Jetstream Atherectomy System features:
- Active Aspiration: extracts debris without device removal, minimizing embolization risk.
- Debulking: to treat multiple lesion morphologies, including calcium, plaque or thrombus.
- Luminal Gain: As reported in the Calcium Study, Jetstream's front-cutting, expandable blades created statistically significant luminal gain in severe and moderate calcium (post versus baseline IVUS measurements)2.
- Front-cutting: to immediately engage tight or occluded lesions.
|Product Description||UPN/Order Code||Catalog Number||GTIN||Unit||Qty|
|Jetstream SC Atherectomy Catheter 1.85 mm||112262-001||PV3118F||08714729889861||Each||1|
|Jetstream?SC Atherectomy Catheter 1.6?mm||112260-001||PV3116F||08714789889830||Each||1|
|Jetstream?XC Atherectomy Catheter 2.4?mm / 3.4 mm?||112266-001||PV41340||08714729889922||Each||1|
|Jetstream?XC Atherectomy Catheter 2.1?mm / 3.0 mm?||112264-001||PV31300||08714729889892||Each||1|
The C-Code used for the Jetstream Atherectomy System is C1724. C-Codes are used for hospital outpatient device reporting for Medicare and some private payers.
Note: Boston Scientific Corporation is not responsible for correct use of codes on submitted claims; this information does not constitute reimbursement or legal advice.
Boston Scientific Reimbursement
Hotline: 1.800.CARDIAC (227.3422)
Medicare National Average Hospital Outpatient Reimbursement
|CPT?||Abbreviated Description||APC||CY2018 Reimbursement|
|37224||?PTA or DCB||5192||$5,085|
|37225||?Atherectomy w/ PTA or DCB||5193||$10,510|
|37226||?Stent w/ PTA or DCB||5193||$10,510|
|37227||?Atherectomy + Stent w/ PTA or DCB||5194||$16,019|
Effective January 1, 2018, CMS discontinued incremental reimbursement, transitional pass-through payment, for Drug Coated Balloons. The reimbursement levels shown above are applicable for hospital outpatient cases involving the use of DCB or non-DCB angioplasty devices.
CPT Copyright 2017 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
Device and procedure decisions depend on medical necessity and the physician's professional judgment. Device costs may vary, and other variable costs may impact economics.